Troy Tompkins

670 total citations
13 papers, 522 citations indexed

About

Troy Tompkins is a scholar working on Oncology, Epidemiology and Physiology. According to data from OpenAlex, Troy Tompkins has authored 13 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Epidemiology and 6 papers in Physiology. Recurrent topics in Troy Tompkins's work include Trypanosoma species research and implications (6 papers), Lysosomal Storage Disorders Research (6 papers) and Polyomavirus and related diseases (6 papers). Troy Tompkins is often cited by papers focused on Trypanosoma species research and implications (6 papers), Lysosomal Storage Disorders Research (6 papers) and Polyomavirus and related diseases (6 papers). Troy Tompkins collaborates with scholars based in United States, Brazil and Israel. Troy Tompkins's co-authors include Igor J. Koralnik, Angela Marzocchetti, Chen Sabrina Tan, Rajesh T. Gandhi, Joseph R. Berger, David B. Clifford, Janice S. Miller, R. Philip Kinkel, Long Ngo and Yiping Chen and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of Virology.

In The Last Decade

Troy Tompkins

13 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Troy Tompkins United States 9 331 231 118 117 107 13 522
A. Woollons United Kingdom 11 124 0.4× 53 0.2× 27 0.2× 91 0.8× 54 0.5× 19 407
Ivan Jelčić Switzerland 12 151 0.5× 86 0.4× 11 0.1× 35 0.3× 31 0.3× 16 351
Trent Walradt United States 6 281 0.8× 182 0.8× 26 0.2× 30 0.3× 151 1.4× 26 457
Jeanette Kaae Denmark 11 255 0.8× 127 0.5× 6 0.1× 77 0.7× 108 1.0× 18 453
M. Price United Kingdom 6 99 0.3× 53 0.2× 20 0.2× 32 0.3× 54 0.5× 9 499
María Inmaculada Domínguez‐Mozo Spain 14 139 0.4× 34 0.1× 19 0.2× 163 1.4× 14 0.1× 40 575
Albertina E. Hodach United States 7 170 0.5× 67 0.3× 23 0.2× 24 0.2× 31 0.3× 12 341
Elena Uleri Italy 11 124 0.4× 27 0.1× 17 0.1× 70 0.6× 17 0.2× 15 527
Marcus Krämer Germany 5 128 0.4× 65 0.3× 9 0.1× 27 0.2× 28 0.3× 6 378
Manish T. Raiji United States 10 261 0.8× 81 0.4× 6 0.1× 17 0.1× 62 0.6× 14 414

Countries citing papers authored by Troy Tompkins

Since Specialization
Citations

This map shows the geographic impact of Troy Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Tompkins more than expected).

Fields of papers citing papers by Troy Tompkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Tompkins. The network helps show where Troy Tompkins may publish in the future.

Co-authorship network of co-authors of Troy Tompkins

This figure shows the co-authorship network connecting the top 25 collaborators of Troy Tompkins. A scholar is included among the top collaborators of Troy Tompkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy Tompkins. Troy Tompkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Melton, Andrew C., Troy Tompkins, Brian Long, et al.. (2016). Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome. Journal of Immunological Methods. 440. 41–51. 14 indexed citations
2.
Long, Brian, Troy Tompkins, Celeste Decker, et al.. (2016). Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study. Clinical Therapeutics. 39(1). 118–129.e3. 26 indexed citations
3.
Schweighardt, Becky, Troy Tompkins, Donald G. Musson, et al.. (2015). Immunogenicity of elosulfase alfa, an enzyme replacement therapy in patients with Morquio syndrome type A: Results from MOR-004, a phase 3 trial. Molecular Genetics and Metabolism. 114(2). S105–S105. 2 indexed citations
4.
Ruane, Therese, Mark E. Haskins, Ping Wang, et al.. (2015). Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations. Molecular Genetics and Metabolism. 117(2). 157–163. 6 indexed citations
5.
Schweighardt, Becky, Troy Tompkins, Lynne Jesaitis, et al.. (2014). Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial. Clinical Therapeutics. 37(5). 1012–1021.e6. 46 indexed citations
6.
Musson, Donald G., Becky Schweighardt, Troy Tompkins, et al.. (2014). Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome. Clinical Pharmacokinetics. 53(12). 1137–1147. 36 indexed citations
7.
Chen, Yiping, Evelyn Bord, Troy Tompkins, et al.. (2009). Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab. New England Journal of Medicine. 361(11). 1067–1074. 159 indexed citations
8.
Marzocchetti, Angela, Troy Tompkins, David B. Clifford, et al.. (2009). Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 73(19). 1551–1558. 131 indexed citations
9.
Marzocchetti, Angela, Marco Antônio Lima, Troy Tompkins, et al.. (2008). Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology. 383(2). 173–177. 19 indexed citations
10.
Marzocchetti, Angela, Christian Wüthrich, Chen Sabrina Tan, et al.. (2008). Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. Journal of NeuroVirology. 14(5). 455–458. 39 indexed citations
11.
Lima, Marco Antônio, Angela Marzocchetti, Patrick Autissier, et al.. (2007). Frequency and Phenotype of JC Virus-Specific CD8 + T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy. Journal of Virology. 81(19). 10835–10835. 1 indexed citations
12.
Lima, Marco Antônio, Angela Marzocchetti, Patrick Autissier, et al.. (2007). Frequency and Phenotype of JC Virus-Specific CD8+T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy. Journal of Virology. 81(7). 3361–3368. 42 indexed citations
13.
Buckstein, Rena, Kevin Imrie, David Spaner, et al.. (2000). In Vivo Purging With Rituximab Prior to Stem Cell Collection Is Associated With Persistent Molecular Evidence of t(14;18) That Often Disappears Post-Transplant in Patients With Follicular Lymphoma. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026